Table of Content

1 Study Coverage
1.1 Hormone Disorder Drug Product Introduction
1.2 Market by Type
1.2.1 Global Hormone Disorder Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Growth Hormone Stimulator
1.2.3 Growth Hormone Inhibitor
1.3 Market by Application
1.3.1 Global Hormone Disorder Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Dwarfism
1.3.3 Gigantism
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Hormone Disorder Drug Sales Estimates and Forecasts 2018-2029
2.2 Global Hormone Disorder Drug Revenue by Region
2.2.1 Global Hormone Disorder Drug Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Hormone Disorder Drug Revenue by Region (2018-2024)
2.2.3 Global Hormone Disorder Drug Revenue by Region (2024-2029)
2.2.4 Global Hormone Disorder Drug Revenue Market Share by Region (2018-2029)
2.3 Global Hormone Disorder Drug Sales Estimates and Forecasts 2018-2029
2.4 Global Hormone Disorder Drug Sales by Region
2.4.1 Global Hormone Disorder Drug Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Hormone Disorder Drug Sales by Region (2018-2024)
2.4.3 Global Hormone Disorder Drug Sales by Region (2024-2029)
2.4.4 Global Hormone Disorder Drug Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Hormone Disorder Drug Sales by Manufacturers
3.1.1 Global Hormone Disorder Drug Sales by Manufacturers (2018-2024)
3.1.2 Global Hormone Disorder Drug Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Hormone Disorder Drug in 2022
3.2 Global Hormone Disorder Drug Revenue by Manufacturers
3.2.1 Global Hormone Disorder Drug Revenue by Manufacturers (2018-2024)
3.2.2 Global Hormone Disorder Drug Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Hormone Disorder Drug Revenue in 2022
3.3 Global Key Players of Hormone Disorder Drug, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Hormone Disorder Drug Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Hormone Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Hormone Disorder Drug, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Hormone Disorder Drug, Product Offered and Application
3.8 Global Key Manufacturers of Hormone Disorder Drug, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Hormone Disorder Drug Sales by Type
4.1.1 Global Hormone Disorder Drug Historical Sales by Type (2018-2024)
4.1.2 Global Hormone Disorder Drug Forecasted Sales by Type (2024-2029)
4.1.3 Global Hormone Disorder Drug Sales Market Share by Type (2018-2029)
4.2 Global Hormone Disorder Drug Revenue by Type
4.2.1 Global Hormone Disorder Drug Historical Revenue by Type (2018-2024)
4.2.2 Global Hormone Disorder Drug Forecasted Revenue by Type (2024-2029)
4.2.3 Global Hormone Disorder Drug Revenue Market Share by Type (2018-2029)
4.3 Global Hormone Disorder Drug Price by Type
4.3.1 Global Hormone Disorder Drug Price by Type (2018-2024)
4.3.2 Global Hormone Disorder Drug Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Hormone Disorder Drug Sales by Application
5.1.1 Global Hormone Disorder Drug Historical Sales by Application (2018-2024)
5.1.2 Global Hormone Disorder Drug Forecasted Sales by Application (2024-2029)
5.1.3 Global Hormone Disorder Drug Sales Market Share by Application (2018-2029)
5.2 Global Hormone Disorder Drug Revenue by Application
5.2.1 Global Hormone Disorder Drug Historical Revenue by Application (2018-2024)
5.2.2 Global Hormone Disorder Drug Forecasted Revenue by Application (2024-2029)
5.2.3 Global Hormone Disorder Drug Revenue Market Share by Application (2018-2029)
5.3 Global Hormone Disorder Drug Price by Application
5.3.1 Global Hormone Disorder Drug Price by Application (2018-2024)
5.3.2 Global Hormone Disorder Drug Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Hormone Disorder Drug Market Size by Type
6.1.1 US & Canada Hormone Disorder Drug Sales by Type (2018-2029)
6.1.2 US & Canada Hormone Disorder Drug Revenue by Type (2018-2029)
6.2 US & Canada Hormone Disorder Drug Market Size by Application
6.2.1 US & Canada Hormone Disorder Drug Sales by Application (2018-2029)
6.2.2 US & Canada Hormone Disorder Drug Revenue by Application (2018-2029)
6.3 US & Canada Hormone Disorder Drug Market Size by Country
6.3.1 US & Canada Hormone Disorder Drug Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Hormone Disorder Drug Sales by Country (2018-2029)
6.3.3 US & Canada Hormone Disorder Drug Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Hormone Disorder Drug Market Size by Type
7.1.1 Europe Hormone Disorder Drug Sales by Type (2018-2029)
7.1.2 Europe Hormone Disorder Drug Revenue by Type (2018-2029)
7.2 Europe Hormone Disorder Drug Market Size by Application
7.2.1 Europe Hormone Disorder Drug Sales by Application (2018-2029)
7.2.2 Europe Hormone Disorder Drug Revenue by Application (2018-2029)
7.3 Europe Hormone Disorder Drug Market Size by Country
7.3.1 Europe Hormone Disorder Drug Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Hormone Disorder Drug Sales by Country (2018-2029)
7.3.3 Europe Hormone Disorder Drug Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Hormone Disorder Drug Market Size
8.1.1 China Hormone Disorder Drug Sales (2018-2029)
8.1.2 China Hormone Disorder Drug Revenue (2018-2029)
8.2 China Hormone Disorder Drug Market Size by Application
8.2.1 China Hormone Disorder Drug Sales by Application (2018-2029)
8.2.2 China Hormone Disorder Drug Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Hormone Disorder Drug Market Size by Type
9.1.1 Asia Hormone Disorder Drug Sales by Type (2018-2029)
9.1.2 Asia Hormone Disorder Drug Revenue by Type (2018-2029)
9.2 Asia Hormone Disorder Drug Market Size by Application
9.2.1 Asia Hormone Disorder Drug Sales by Application (2018-2029)
9.2.2 Asia Hormone Disorder Drug Revenue by Application (2018-2029)
9.3 Asia Hormone Disorder Drug Sales by Region
9.3.1 Asia Hormone Disorder Drug Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Hormone Disorder Drug Revenue by Region (2018-2029)
9.3.3 Asia Hormone Disorder Drug Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Hormone Disorder Drug Market Size by Type
10.1.1 Middle East, Africa and Latin America Hormone Disorder Drug Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Hormone Disorder Drug Market Size by Application
10.2.1 Middle East, Africa and Latin America Hormone Disorder Drug Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Hormone Disorder Drug Sales by Country
10.3.1 Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Hormone Disorder Drug Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Teva Pharmaceutical Industries Ltd
11.1.1 Teva Pharmaceutical Industries Ltd Company Information
11.1.2 Teva Pharmaceutical Industries Ltd Overview
11.1.3 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.2 Amneal Pharmaceutical Inc
11.2.1 Amneal Pharmaceutical Inc Company Information
11.2.2 Amneal Pharmaceutical Inc Overview
11.2.3 Amneal Pharmaceutical Inc Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 Amneal Pharmaceutical Inc Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Amneal Pharmaceutical Inc Recent Developments
11.3 Mayne Pharma Group Limited
11.3.1 Mayne Pharma Group Limited Company Information
11.3.2 Mayne Pharma Group Limited Overview
11.3.3 Mayne Pharma Group Limited Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Mayne Pharma Group Limited Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mayne Pharma Group Limited Recent Developments
11.4 Merck KGaA
11.4.1 Merck KGaA Company Information
11.4.2 Merck KGaA Overview
11.4.3 Merck KGaA Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Merck KGaA Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Merck KGaA Recent Developments
11.5 Sanofi
11.5.1 Sanofi Company Information
11.5.2 Sanofi Overview
11.5.3 Sanofi Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Sanofi Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Sanofi Recent Developments
11.6 Sun Pharmaceutical Industries Ltd
11.6.1 Sun Pharmaceutical Industries Ltd Company Information
11.6.2 Sun Pharmaceutical Industries Ltd Overview
11.6.3 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Sun Pharmaceutical Industries Ltd Recent Developments
11.7 Novartis AG
11.7.1 Novartis AG Company Information
11.7.2 Novartis AG Overview
11.7.3 Novartis AG Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 Novartis AG Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Novartis AG Recent Developments
11.8 F. Hoffmann-La Roche Ltd
11.8.1 F. Hoffmann-La Roche Ltd Company Information
11.8.2 F. Hoffmann-La Roche Ltd Overview
11.8.3 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 F. Hoffmann-La Roche Ltd Recent Developments
11.9 Abbott
11.9.1 Abbott Company Information
11.9.2 Abbott Overview
11.9.3 Abbott Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 Abbott Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Abbott Recent Developments
11.10 PT. Daewoong Pharmaceutical Company
11.10.1 PT. Daewoong Pharmaceutical Company Company Information
11.10.2 PT. Daewoong Pharmaceutical Company Overview
11.10.3 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 PT. Daewoong Pharmaceutical Company Recent Developments
11.11 Genentech, Inc
11.11.1 Genentech, Inc Company Information
11.11.2 Genentech, Inc Overview
11.11.3 Genentech, Inc Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Genentech, Inc Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Genentech, Inc Recent Developments
11.12 Bausch Health Companies Inc
11.12.1 Bausch Health Companies Inc Company Information
11.12.2 Bausch Health Companies Inc Overview
11.12.3 Bausch Health Companies Inc Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Bausch Health Companies Inc Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Bausch Health Companies Inc Recent Developments
11.13 Lilly
11.13.1 Lilly Company Information
11.13.2 Lilly Overview
11.13.3 Lilly Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Lilly Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Lilly Recent Developments
11.14 Ipsen Pharma
11.14.1 Ipsen Pharma Company Information
11.14.2 Ipsen Pharma Overview
11.14.3 Ipsen Pharma Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Ipsen Pharma Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Ipsen Pharma Recent Developments
11.15 Ferring B.V
11.15.1 Ferring B.V Company Information
11.15.2 Ferring B.V Overview
11.15.3 Ferring B.V Hormone Disorder Drug Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Ferring B.V Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Ferring B.V Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Hormone Disorder Drug Industry Chain Analysis
12.2 Hormone Disorder Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Hormone Disorder Drug Production Mode & Process
12.4 Hormone Disorder Drug Sales and Marketing
12.4.1 Hormone Disorder Drug Sales Channels
12.4.2 Hormone Disorder Drug Distributors
12.5 Hormone Disorder Drug Customers
13 Market Dynamics
13.1 Hormone Disorder Drug Industry Trends
13.2 Hormone Disorder Drug Market Drivers
13.3 Hormone Disorder Drug Market Challenges
13.4 Hormone Disorder Drug Market Restraints
14 Key Findings in The Global Hormone Disorder Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Hormone Disorder Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Growth Hormone Stimulator
Table 3. Major Manufacturers of Growth Hormone Inhibitor
Table 4. Global Hormone Disorder Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Hormone Disorder Drug Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Hormone Disorder Drug Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Hormone Disorder Drug Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Hormone Disorder Drug Revenue Market Share by Region (2018-2024)
Table 9. Global Hormone Disorder Drug Revenue Market Share by Region (2024-2029)
Table 10. Global Hormone Disorder Drug Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Hormone Disorder Drug Sales by Region (2018-2024) & (K Units)
Table 12. Global Hormone Disorder Drug Sales by Region (2024-2029) & (K Units)
Table 13. Global Hormone Disorder Drug Sales Market Share by Region (2018-2024)
Table 14. Global Hormone Disorder Drug Sales Market Share by Region (2024-2029)
Table 15. Global Hormone Disorder Drug Sales by Manufacturers (2018-2024) & (K Units)
Table 16. Global Hormone Disorder Drug Sales Share by Manufacturers (2018-2024)
Table 17. Global Hormone Disorder Drug Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Hormone Disorder Drug Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Hormone Disorder Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Hormone Disorder Drug Price by Manufacturers 2018-2024 (US$/Unit)
Table 21. Global Hormone Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Hormone Disorder Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hormone Disorder Drug as of 2022)
Table 23. Global Key Manufacturers of Hormone Disorder Drug, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Hormone Disorder Drug, Product Offered and Application
Table 25. Global Key Manufacturers of Hormone Disorder Drug, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Hormone Disorder Drug Sales by Type (2018-2024) & (K Units)
Table 28. Global Hormone Disorder Drug Sales by Type (2024-2029) & (K Units)
Table 29. Global Hormone Disorder Drug Sales Share by Type (2018-2024)
Table 30. Global Hormone Disorder Drug Sales Share by Type (2024-2029)
Table 31. Global Hormone Disorder Drug Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Hormone Disorder Drug Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Hormone Disorder Drug Revenue Share by Type (2018-2024)
Table 34. Global Hormone Disorder Drug Revenue Share by Type (2024-2029)
Table 35. Hormone Disorder Drug Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Hormone Disorder Drug Price Forecast by Type (2024-2029) & (US$/Unit)
Table 37. Global Hormone Disorder Drug Sales by Application (2018-2024) & (K Units)
Table 38. Global Hormone Disorder Drug Sales by Application (2024-2029) & (K Units)
Table 39. Global Hormone Disorder Drug Sales Share by Application (2018-2024)
Table 40. Global Hormone Disorder Drug Sales Share by Application (2024-2029)
Table 41. Global Hormone Disorder Drug Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Hormone Disorder Drug Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Hormone Disorder Drug Revenue Share by Application (2018-2024)
Table 44. Global Hormone Disorder Drug Revenue Share by Application (2024-2029)
Table 45. Hormone Disorder Drug Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Hormone Disorder Drug Price Forecast by Application (2024-2029) & (US$/Unit)
Table 47. US & Canada Hormone Disorder Drug Sales by Type (2018-2024) & (K Units)
Table 48. US & Canada Hormone Disorder Drug Sales by Type (2024-2029) & (K Units)
Table 49. US & Canada Hormone Disorder Drug Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Hormone Disorder Drug Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Hormone Disorder Drug Sales by Application (2018-2024) & (K Units)
Table 52. US & Canada Hormone Disorder Drug Sales by Application (2024-2029) & (K Units)
Table 53. US & Canada Hormone Disorder Drug Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Hormone Disorder Drug Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Hormone Disorder Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Hormone Disorder Drug Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Hormone Disorder Drug Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Hormone Disorder Drug Sales by Country (2018-2024) & (K Units)
Table 59. US & Canada Hormone Disorder Drug Sales by Country (2024-2029) & (K Units)
Table 60. Europe Hormone Disorder Drug Sales by Type (2018-2024) & (K Units)
Table 61. Europe Hormone Disorder Drug Sales by Type (2024-2029) & (K Units)
Table 62. Europe Hormone Disorder Drug Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Hormone Disorder Drug Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Hormone Disorder Drug Sales by Application (2018-2024) & (K Units)
Table 65. Europe Hormone Disorder Drug Sales by Application (2024-2029) & (K Units)
Table 66. Europe Hormone Disorder Drug Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Hormone Disorder Drug Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Hormone Disorder Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Hormone Disorder Drug Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Hormone Disorder Drug Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Hormone Disorder Drug Sales by Country (2018-2024) & (K Units)
Table 72. Europe Hormone Disorder Drug Sales by Country (2024-2029) & (K Units)
Table 73. China Hormone Disorder Drug Sales by Type (2018-2024) & (K Units)
Table 74. China Hormone Disorder Drug Sales by Type (2024-2029) & (K Units)
Table 75. China Hormone Disorder Drug Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Hormone Disorder Drug Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Hormone Disorder Drug Sales by Application (2018-2024) & (K Units)
Table 78. China Hormone Disorder Drug Sales by Application (2024-2029) & (K Units)
Table 79. China Hormone Disorder Drug Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Hormone Disorder Drug Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Hormone Disorder Drug Sales by Type (2018-2024) & (K Units)
Table 82. Asia Hormone Disorder Drug Sales by Type (2024-2029) & (K Units)
Table 83. Asia Hormone Disorder Drug Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Hormone Disorder Drug Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Hormone Disorder Drug Sales by Application (2018-2024) & (K Units)
Table 86. Asia Hormone Disorder Drug Sales by Application (2024-2029) & (K Units)
Table 87. Asia Hormone Disorder Drug Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Hormone Disorder Drug Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Hormone Disorder Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Hormone Disorder Drug Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Hormone Disorder Drug Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Hormone Disorder Drug Sales by Region (2018-2024) & (K Units)
Table 93. Asia Hormone Disorder Drug Sales by Region (2024-2029) & (K Units)
Table 94. Middle East, Africa and Latin America Hormone Disorder Drug Sales by Type (2018-2024) & (K Units)
Table 95. Middle East, Africa and Latin America Hormone Disorder Drug Sales by Type (2024-2029) & (K Units)
Table 96. Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Hormone Disorder Drug Sales by Application (2018-2024) & (K Units)
Table 99. Middle East, Africa and Latin America Hormone Disorder Drug Sales by Application (2024-2029) & (K Units)
Table 100. Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Hormone Disorder Drug Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Hormone Disorder Drug Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Hormone Disorder Drug Sales by Country (2018-2024) & (K Units)
Table 106. Middle East, Africa and Latin America Hormone Disorder Drug Sales by Country (2024-2029) & (K Units)
Table 107. Teva Pharmaceutical Industries Ltd Company Information
Table 108. Teva Pharmaceutical Industries Ltd Description and Major Businesses
Table 109. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Teva Pharmaceutical Industries Ltd Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Teva Pharmaceutical Industries Ltd Recent Developments
Table 112. Amneal Pharmaceutical Inc Company Information
Table 113. Amneal Pharmaceutical Inc Description and Major Businesses
Table 114. Amneal Pharmaceutical Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. Amneal Pharmaceutical Inc Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Amneal Pharmaceutical Inc Recent Developments
Table 117. Mayne Pharma Group Limited Company Information
Table 118. Mayne Pharma Group Limited Description and Major Businesses
Table 119. Mayne Pharma Group Limited Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Mayne Pharma Group Limited Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Mayne Pharma Group Limited Recent Developments
Table 122. Merck KGaA Company Information
Table 123. Merck KGaA Description and Major Businesses
Table 124. Merck KGaA Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Merck KGaA Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Merck KGaA Recent Developments
Table 127. Sanofi Company Information
Table 128. Sanofi Description and Major Businesses
Table 129. Sanofi Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Sanofi Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Sanofi Recent Developments
Table 132. Sun Pharmaceutical Industries Ltd Company Information
Table 133. Sun Pharmaceutical Industries Ltd Description and Major Businesses
Table 134. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Sun Pharmaceutical Industries Ltd Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Sun Pharmaceutical Industries Ltd Recent Developments
Table 137. Novartis AG Company Information
Table 138. Novartis AG Description and Major Businesses
Table 139. Novartis AG Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Novartis AG Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Novartis AG Recent Developments
Table 142. F. Hoffmann-La Roche Ltd Company Information
Table 143. F. Hoffmann-La Roche Ltd Description and Major Businesses
Table 144. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. F. Hoffmann-La Roche Ltd Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. F. Hoffmann-La Roche Ltd Recent Developments
Table 147. Abbott Company Information
Table 148. Abbott Description and Major Businesses
Table 149. Abbott Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Abbott Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Abbott Recent Developments
Table 152. PT. Daewoong Pharmaceutical Company Company Information
Table 153. PT. Daewoong Pharmaceutical Company Description and Major Businesses
Table 154. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. PT. Daewoong Pharmaceutical Company Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. PT. Daewoong Pharmaceutical Company Recent Developments
Table 157. Genentech, Inc Company Information
Table 158. Genentech, Inc Description and Major Businesses
Table 159. Genentech, Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Genentech, Inc Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Genentech, Inc Recent Developments
Table 162. Bausch Health Companies Inc Company Information
Table 163. Bausch Health Companies Inc Description and Major Businesses
Table 164. Bausch Health Companies Inc Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Bausch Health Companies Inc Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Bausch Health Companies Inc Recent Developments
Table 167. Lilly Company Information
Table 168. Lilly Description and Major Businesses
Table 169. Lilly Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Lilly Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Lilly Recent Developments
Table 172. Ipsen Pharma Company Information
Table 173. Ipsen Pharma Description and Major Businesses
Table 174. Ipsen Pharma Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Ipsen Pharma Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Ipsen Pharma Recent Developments
Table 177. Ferring B.V Company Information
Table 178. Ferring B.V Description and Major Businesses
Table 179. Ferring B.V Hormone Disorder Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Ferring B.V Hormone Disorder Drug Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Ferring B.V Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Hormone Disorder Drug Distributors List
Table 185. Hormone Disorder Drug Customers List
Table 186. Hormone Disorder Drug Market Trends
Table 187. Hormone Disorder Drug Market Drivers
Table 188. Hormone Disorder Drug Market Challenges
Table 189. Hormone Disorder Drug Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Hormone Disorder Drug Product Picture
Figure 2. Global Hormone Disorder Drug Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hormone Disorder Drug Market Share by Type in 2022 & 2029
Figure 4. Growth Hormone Stimulator Product Picture
Figure 5. Growth Hormone Inhibitor Product Picture
Figure 6. Global Hormone Disorder Drug Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Hormone Disorder Drug Market Share by Application in 2022 & 2029
Figure 8. Dwarfism
Figure 9. Gigantism
Figure 10. Other
Figure 11. Hormone Disorder Drug Report Years Considered
Figure 12. Global Hormone Disorder Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Hormone Disorder Drug Revenue 2018-2029 (US$ Million)
Figure 14. Global Hormone Disorder Drug Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Hormone Disorder Drug Revenue Market Share by Region (2018-2029)
Figure 16. Global Hormone Disorder Drug Sales 2018-2029 ((K Units)
Figure 17. Global Hormone Disorder Drug Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Hormone Disorder Drug Sales YoY (2018-2029) & (K Units)
Figure 19. US & Canada Hormone Disorder Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Hormone Disorder Drug Sales YoY (2018-2029) & (K Units)
Figure 21. Europe Hormone Disorder Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Hormone Disorder Drug Sales YoY (2018-2029) & (K Units)
Figure 23. China Hormone Disorder Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Hormone Disorder Drug Sales YoY (2018-2029) & (K Units)
Figure 25. Asia (excluding China) Hormone Disorder Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Hormone Disorder Drug Sales YoY (2018-2029) & (K Units)
Figure 27. Middle East, Africa and Latin America Hormone Disorder Drug Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Hormone Disorder Drug Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Hormone Disorder Drug in the World: Market Share by Hormone Disorder Drug Revenue in 2022
Figure 30. Global Hormone Disorder Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Hormone Disorder Drug Sales Market Share by Type (2018-2029)
Figure 32. Global Hormone Disorder Drug Revenue Market Share by Type (2018-2029)
Figure 33. Global Hormone Disorder Drug Sales Market Share by Application (2018-2029)
Figure 34. Global Hormone Disorder Drug Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Hormone Disorder Drug Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Hormone Disorder Drug Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Hormone Disorder Drug Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Hormone Disorder Drug Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Hormone Disorder Drug Revenue Share by Country (2018-2029)
Figure 40. US & Canada Hormone Disorder Drug Sales Share by Country (2018-2029)
Figure 41. U.S. Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Hormone Disorder Drug Sales Market Share by Type (2018-2029)
Figure 44. Europe Hormone Disorder Drug Revenue Market Share by Type (2018-2029)
Figure 45. Europe Hormone Disorder Drug Sales Market Share by Application (2018-2029)
Figure 46. Europe Hormone Disorder Drug Revenue Market Share by Application (2018-2029)
Figure 47. Europe Hormone Disorder Drug Revenue Share by Country (2018-2029)
Figure 48. Europe Hormone Disorder Drug Sales Share by Country (2018-2029)
Figure 49. Germany Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 50. France Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 54. China Hormone Disorder Drug Sales Market Share by Type (2018-2029)
Figure 55. China Hormone Disorder Drug Revenue Market Share by Type (2018-2029)
Figure 56. China Hormone Disorder Drug Sales Market Share by Application (2018-2029)
Figure 57. China Hormone Disorder Drug Revenue Market Share by Application (2018-2029)
Figure 58. Asia Hormone Disorder Drug Sales Market Share by Type (2018-2029)
Figure 59. Asia Hormone Disorder Drug Revenue Market Share by Type (2018-2029)
Figure 60. Asia Hormone Disorder Drug Sales Market Share by Application (2018-2029)
Figure 61. Asia Hormone Disorder Drug Revenue Market Share by Application (2018-2029)
Figure 62. Asia Hormone Disorder Drug Revenue Share by Region (2018-2029)
Figure 63. Asia Hormone Disorder Drug Sales Share by Region (2018-2029)
Figure 64. Japan Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 68. India Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Hormone Disorder Drug Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Hormone Disorder Drug Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Hormone Disorder Drug Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Hormone Disorder Drug Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Hormone Disorder Drug Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Hormone Disorder Drug Sales Share by Country (2018-2029)
Figure 75. Brazil Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Hormone Disorder Drug Revenue (2018-2029) & (US$ Million)
Figure 80. Hormone Disorder Drug Value Chain
Figure 81. Hormone Disorder Drug Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed